Results per Page:
Two Fred Hutch students receive American Society for Hematology graduate awards
The two-year, $40,000 annual awards support emerging researchers studying myelodysplastic syndromes and pediatric leukemia
For many blood cancer patients, CAR T-cell therapy is game-changing
In this episode of From Bench to Bedside and Beyond, Dr. Mazyar Shadman explains why CAR T-cell therapy should be considered for patients who relapse
New drug regimen prevents both chronic and acute graft-versus-host disease
From Dr. Masumi Ueda Oshima and colleagues, Clinical Research Division
Grateful for her husband’s life-saving care, she vowed to get a job at Fred Hutch
In this episode of From Bench to Bedside and Beyond, Tiffany Bucklin talks about her husband’s treatment for leukemia
Premature immune aging occurs in children with leukemia
From Drs. Kavita Dhodapkar and Madhav Dhodapkar, Translational Science & Therapeutics Division
American Society of Clinical Oncology honors Fred Hutch and UW hematology-oncology fellows
Five early-career researchers to each receive $50,000 toward innovative cancer research projects
Giving that feels ‘beyond meaningful’
The Steinberg family honors the memory of loved ones by celebrating and supporting a profession that takes caring to another level
Dr. Filippo Milano receives inaugural Endowed Chair in Cord Blood Research
Unrestricted funding will help grow Fred Hutch’s Cord Blood Transplant Program so that ‘every patient has a donor’
Fred Hutch launches Atlas of Inspiring Hispanic/Latinx Scientists
Online atlas recognizes contributions of Hispanic and Latinx scientists
Dedicated supporters at the Heart of the Hutch
Using creativity and passion to support Fred Hutch research in good times and bad
Blood and Marrow Transplant Reunion returns to Fred Hutch
Hundreds gather in Seattle to celebrate life, science and cancer survivorship
Dr. Brenda Sandmaier named president of American Society for Transplantation and Cellular Therapy
Transplant immunotherapy physician-scientist will serve 2022-2023 term
Toward better cures for kids with AML: Q&A with Dr. Soheil Meshinchi
How researchers are developing personalized therapies for the deadliest childhood leukemia that have fewer side effects
Q&A: Returning to school, post-transplant
As schools reopen for in-person learning, what should bone marrow transplant recipients do?